Anyone taking Parkinson medication Rasagilina toLife, 1 mg, from a batch numbered T002, valid to November 2024, must stop doing so as soon as possible and contact their doctor. Any pharmacies selling the medication should withdraw it immediately from sale. Supply company Towa Pharmaceutical SA (based in Japan) is recalling the batch due to “an impurity above the acceptable limit” having been discovered within it.
